The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ADXS11-001 immunotherapy targeting HPV-E7: Final results from a phase 2 study in Indian women with recurrent cervical cancer.
Partha Basu
Research Funding - Advaxis
Ajay O. Mehta
No relevant relationships to disclose
Minish Mahendra Jain
No relevant relationships to disclose
Sudeep Gupta
No relevant relationships to disclose
Rajnish Vasant Nagarkar
No relevant relationships to disclose
Vijay Kumar
No relevant relationships to disclose
Sumana Premkumar
No relevant relationships to disclose
Rakesh Neve
No relevant relationships to disclose
Subhashini John
No relevant relationships to disclose
Robert G. Petit
Employment or Leadership Position - Advaxis